Caricamento...
Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets
Giant cell arteritis (GCA) is the most common idiopathic systemic vasculitis in persons aged 50 years or greater. Treatment options for GCA, to-date, have been limited and have consisted primarily of glucocorticoids. Significant advances in the understanding of the genetic and cellular mechanisms in...
Salvato in:
| Pubblicato in: | BMC Rheumatol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6383596/ https://ncbi.nlm.nih.gov/pubmed/30886946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-017-0004-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|